CD19 and B-cell chronic lymphocytic leukemia: CLL is a chronic malignancy of lymphocytes common in adults.123 Allogeneic stem cell transplantation is the only current CLL therapy approach.124 Patients with chronic and high-risk CLL are treated with CD19 CAR-T cells.111 Several studies have been reviewed to evaluate the effect of engineered cells on individuals with CLL.